Clinical Trials
13 trialsNCT06181656 2026-05-20
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
M.D. Anderson Cancer Center
Recruiting
NCT07258160 2026-01-09
Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2 Recruiting
NCT07267234 2025-12-05
PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)
Second Affiliated Hospital of Soochow University
Phase 2 Not yet recruiting
NCT04019262 2025-06-18
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
University of Pittsburgh
Phase 1/2 Active not recruiting
NCT01660347 2025-05-02
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Thomas Jefferson University
Phase NA Withdrawn
NCT06584006 2024-09-19
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
The First Affiliated Hospital of Xiamen University
Phase 2 Recruiting
NCT02659800 2023-10-06
Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT02799251 2021-01-20
EVALYMPH
Centre Hospitalier Universitaire de Saint Etienne
Completed
NCT03549546 2019-07-26
POIR
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Completed
NCT01653834 2018-11-07
Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT02490930 2017-09-13
A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT01306188 2015-07-02
LYMPHOS1
Centre Leon Berard
Completed
NCT01368107 2015-02-09
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
Centre Leon Berard
Phase 2 Completed